Ignite Creation Date:
2025-12-25 @ 3:00 AM
Ignite Modification Date:
2025-12-31 @ 5:58 AM
Study NCT ID:
NCT05426733
Status:
ENROLLING_BY_INVITATION
Last Update Posted:
2025-12-03
First Post:
2022-06-13
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
An Open-label Extension Study to Evaluate Long-term Efficacy and Safety of Odevixibat in Children With Biliary Atresia
Sponsor:
Albireo, an Ipsen Company
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-07-05
Start Date Type:
ACTUAL
Primary Completion Date:
2028-08-31
Primary Completion Date Type:
ESTIMATED
Completion Date:
2028-08-31
Completion Date Type:
ESTIMATED
First Submit Date:
2022-06-13
First Submit QC Date:
None
Study First Post Date:
2022-06-22
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-11-25
Last Update Post Date:
2025-12-03
Last Update Post Date Type:
ESTIMATED